Blog

  • US Hospitals grapple with financial stress as costs surge

    US Hospitals grapple with financial stress as costs surge

    Hospitals and health systems have been struggling with mounting cost pressures, and they probably aren’t going to see much relief in the months ahead.

    The median operating margins for health systems were 1% in August, according to data from Strata Decision Technology released last week. And that’s not an anomaly, as operating margins have hovered around 1% through much of 2025.

    Hospitals have seen rising expenses for both supplies and labor, and they’ve also seen interruptions in funding from the federal government.

    Steve Wasson, chief data and intelligence officer for Strata Decision Technology, tells Chief Healthcare Executive® that he doesn’t expect to see much improvement in operating margins in the near future.

    “I would expect some additional volatility in the next two quarters,” Wasson says. “This is not smooth sailing, which is different from when we entered 2025.”

    Labor costs remain a challenge for health systems, although providers have succeeded in reducing their use of temporary staffing agencies, helping them curb costs.

    However, costs for non-labor expenses have been rising at a faster rate. Non-labor costs rose 5.7% year-over year in August, while labor expenses climbed 4.6%.

    Hospitals have seen higher prices for supplies, particularly for prescription drugs.

    “Drug prices have been really elevated, and not just like a couple percentage points more, but significantly higher,” he says, adding, “Drug costs have been eating away at a lot of margin.”

    Even without factoring in tariffs, health systems are likely to see high prices in drugs. Leaders projecting drug prices are likely experiencing some heartburn, he says.

    “It’s really hard right now to predict what your drug costs are going to be over the next couple of quarters, because we’ve seen just big spikes,” he says.

    Revenue gains eaten by costs
    Hospitals are seeing improved revenues, with August representing the 28th consecutive month of gross revenues rising year-over-year, according to Strata’s data.

    Outpatient revenue continues to rise at a faster clip than inpatient revenues. In August, outpatient revenue rose 6.3% year-over-year, while inpatient revenues increased by 4.3%.

    Even though health systems see less revenue from shifting some services to outpatient facilities, “it’s higher margin,” Wasson says.

    “So it’s better for their business to put that service in the outpatient when they can,” he says.

    Health systems are seeing solid volume in both inpatient and outpatient settings. But even with better revenues, hospitals are still facing thin margins due to higher expenses.

    “People have been really hard at work trying to get their revenues up through contract negotiations, but it’s eaten away by these costs,” Wasson says.

    Signs of trouble
    Hospitals could also see more financial pressures with more Americans out of work, and Wasson says that’s another reason he expects hospitals to continue to see modest margins in the coming months.

    “I always say this: keep your eye on the unemployment rate. Unemployment is ticking up,” he says.

    With more people without jobs, they won’t have commercial insurance, and would enter into “a self-pay category,” he adds.

    “That is not good news for health systems, because they count on the commercial lives to kind of offset some of these other things,” he says.

    Hospitals and health systems have warned that looming Medicaid cuts have devastating consequences. More than 10 million Americans are projected to lose Medicaid coverage over the next decade under the tax package brokered by President Trump and Republicans in Congress. Changes in Medicaid programs, including work requirements for beneficiaries, won’t be felt until the end of next year, analysts say.

    But hospitals and health systems are taking steps now to deal with those mounting challenges, and Wasson says providers need to be making plans right now.

    “They have to because, you look at your service line patterns, and you look at your payer mix, and you’re forecasting out where your investments are going to be,” Wasson says.

    “Hospitals don’t move super fast,” he adds. “They plot out years ahead. So, ‘what’s our payer mix going to be two years from now,’ is absolutely a question that they ask themselves. And Medicaid is shifting, and so this is definitely factoring into their plans and their investments.”

    With hospitals and health systems likely to see more volatility, Wasson says it’s important for executives to understand their service lines and their costs. “If you don’t know what they are, then you can’t make adjustments,” he says.

    Healthcare leaders should also be expecting more headwinds.

    “Volatility ahead, volatility in your reimbursement, volatility in your cost for drugs specifically,” he says. “So if you can plan around that, I would.” Chief Healthcare Executive

  • PVR Inox faces CCI probe for alleged producer fee

    PVR Inox faces CCI probe for alleged producer fee

    The Competition Commission of India (CCI) has ordered an investigation into multiplex major PVR Inox following allegations that it continues to levy the virtual digital fee (VDF) on film producers, charges that were meant to be phased out years ago.

    The probe follows a complaint by the Film and Television Producers’ Guild of India, which argued that the country’s largest cinema chain is engaging in anti-competitive practices by collecting the fee. The VDF was introduced in 2007 to finance the costly transition from analogue projectors to digital cinema systems. While Hollywood studios stopped paying the charge nearly a decade after completing the switch, Indian producers say they are still forced to bear the expense.

    The Guild said the continued levy unfairly penalises smaller and mid-sized producers, restricting their ability to compete with larger players.

    In its order issued September 30, as per media reports, the CCI observed a prima facie violation of competition rules and directed its Director General (DG) to conduct a detailed probe. The DG has been asked to submit findings within 90 days and examine whether company executives were directly responsible for the alleged anti-competitive behaviour.

    The CCI stressed that its observations should not be viewed as a final decision, with the investigation to proceed independently.

    Meanwhile, in its financial performance, PVR Inox narrowed its consolidated loss to ₹54 crore in Q1FY26, compared to a ₹1,790 crore loss in the same period last year. Revenue from operations grew 23% year-on-year to ₹1,469 crore, driven by a stronger slate of films and higher footfalls, while other income rose 13% to ₹32.4 crore. Storyboard8

  • BSNL leads the satellite spectrum race

    BSNL leads the satellite spectrum race

    India is about to open up commercial satellite spectrum for private players like Starlink and Jio Satellite, but BSNL has a real advantage.

    Thanks to its existing satcom services and much lower regulatory fees—just 1% of adjusted gross revenue versus the 4% likely for private companies—BSNL is in a strong position, especially since it already serves strategic and government users.

    BSNL’s satellite messaging demo
    Last year, BSNL teamed up with US-based Viasat to demo India’s first two-way direct-to-device messaging using geostationary satellites.
    The cool part? Regular smartphones can connect straight to satellites using commercial smartphones enabled for NTN connectivity, following global standards (3GPP Release 17).
    This could be a game-changer for people in remote areas where mobile networks just don’t reach. Starlink is working on something similar too.

    What’s next for BSNL?
    Right now, BSNL operates under a special GSPS license while waiting for the Department of Telecommunications (DoT) to finalize how spectrum will be priced and shared with private firms.
    The details here will shape how—and how much—BSNL can expand its direct-to-device services commercially.
    For now, everyone’s watching as DoT works out the numbers. NewsBytes App

  • ESPN retains Big South rights through 2031

    ESPN retains Big South rights through 2031

    International sports broadcaster ESPN has renewed its domestic rights for the Big South US college sports conference, for another six years.

    The new agreement, which will run through the 2030-31 academic year, extends a relationship that began in 1991 and will see the bulk of Big South competition remain on the ESPN+ streaming service – its primary home since 2018 when ESPN+ was launched.

    The package spans several sports across the conference, including American football, men’s and women’s basketball and soccer, women’s volleyball and lacrosse, baseball, and softball.

    Big South commissioner Sherika A. Montgomery said: “Our extended agreement is a testament to ESPN’s strong commitment to our Conference, the compelling experiences of our student-athletes, and the competitive excellence that defines our sport programs – especially in basketball.

    “This enhanced partnership significantly elevates our brand visibility, recognition, and reputation on a national level. More importantly, it provides our student-athletes with a broader platform to compete, excel, and share their stories with a wider audience.”

    The rights renewal comes three months after ESPN agreed to a similar six-year streaming rights deal with the Big East Conference that will see a minimum of 75 women’s basketball and 200 Olympic sports events stream on the ESPN+ service annually.

    ESPN’s other college sports offerings include the Atlantic Coast Conference, under a deal renewed earlier this year through the 2035-36 academic year, while the broadcaster’s biggest college sports deal is an eight-year, $920 million tie-up with the NCAA, the governing body of college athletics in the US, announced in January 2024.

    The deal, which started with the 2024-25 academic year and runs through 2031-32, includes domestic rights to 40 championships – 21 women’s and 19 men’s events – and international rights to the same championships as well as the Division I men’s basketball tournament.

    It encompasses several top college sports, including American football, baseball, basketball, lacrosse, tennis, gymnastics, and volleyball.

    However, the contract does not include several marquee games from American football and basketball, including the Division I men’s basketball’s ‘March Madness’ tournament, which is shown by Paramount Global and Warner Bros. Discovery via national network CBS and the Turner cable networks. Sportcal

  • Afghanistan sees First Nationwide Internet blackout

    Afghanistan sees First Nationwide Internet blackout

    An internet blackout hit Afghanistan on Monday, with local media reporting a potential nationwide cut of fibre-optic services as part of a Taliban crackdown on immorality.

    It’s the first time Afghanistan has experienced a shutdown of this kind since the former insurgents seized power in August 2021.

    Earlier this month, several provinces lost fibre-optic connections after Taliban leader Hibatullah Akhundzada issued a decree banning the service to prevent immorality.

    On Monday, internet-access advocacy group Netblocks said that live metrics showed connectivity in Afghanistan had collapsed to 14 per cent of ordinary levels, with a near-total nationwide telecoms disruption in effect.

    The incident is likely to severely limit the public’s ability to contact the outside world, the group added.

    The Associated Press was unable to contact its Kabul bureau, as well as journalists in the provinces of Nangarhar and Helmand. There was no confirmation of the blackout from the Taliban government, which relies heavily on messaging apps and social media.

    The private TOLO News TV channel said sources had confirmed that fiber-optic internet could be cut all over the country starting Monday. Business Standard

  • Flexible Endoscopes Industry to cross USD 20.13B

    Flexible Endoscopes Industry to cross USD 20.13B

    The global flexible endoscopes market has emerged as a critical segment within the medical devices industry, driven by rising demand for minimally invasive procedures and early disease diagnosis. According to recent insights, the market was valued at USD 11.93 billion in 2023 and is projected to reach USD 20.13 billion by 2032, growing at a CAGR of 6.02% during the forecast period (2024-2032).

    Flexible endoscopes are medical devices designed to provide real-time visualization of internal organs for both diagnostic and therapeutic purposes. Unlike rigid scopes, they offer enhanced maneuverability, patient comfort, and versatility in addressing conditions across gastrointestinal, pulmonary, urological, and gynecological domains. Their ability to support minimally invasive techniques makes them indispensable in modern healthcare systems.

    One of the key growth drivers of this market is the increasing prevalence of chronic diseases such as gastrointestinal disorders, cancer, and respiratory illnesses. These conditions often require frequent diagnostic imaging, boosting demand for advanced endoscopy solutions. Additionally, the aging global population is more susceptible to such diseases, further fueling adoption.

    Technological advancements are reshaping the competitive landscape. From AI-assisted diagnostics to robot-assisted endoscopy and single-use flexible endoscopes designed to reduce cross-contamination, manufacturers are innovating rapidly to meet evolving clinical standards. The integration of high-definition imaging and narrow-band visualization is also enhancing diagnostic accuracy.

    Regionally, North America leads the market, owing to its robust healthcare infrastructure, favorable reimbursement policies, and the presence of global medical device giants like Olympus, Stryker, and Boston Scientific. Meanwhile, the Asia-Pacific region is set to record the fastest CAGR, supported by rising healthcare expenditure, expanding hospital networks, and growing awareness of early disease detection.

    Overall, the flexible endoscopes market presents significant whitespace opportunities, particularly in AI-enabled imaging, robotic integration, and single-use device production, which are expected to redefine patient care standards in the coming decade.

    Market segmentation
    The flexible endoscopes market segmentation provides insights into growth trends across different product categories and end-user industries.

    By product type, gastrointestinal endoscopes dominate the market due to the high incidence of digestive system disorders and the rising adoption of colonoscopy and gastroscopy for early cancer detection. Other key product categories include bronchoscopes, laparoscopes, laryngoscopes, and ureteroscopes. Emerging product segments, such as neuroendoscopes and hysteroscopes, are witnessing rising adoption as minimally invasive techniques gain popularity in neurology and gynecology procedures. Additionally, innovations in fiber-based holographic and 3D visualization tools are expected to further enhance product performance and clinical adoption.

    By end-use, hospitals and clinics account for the largest share due to their ability to handle high patient volumes, integrate advanced diagnostic equipment, and invest in robotic-assisted and AI-enabled systems. Ambulatory surgical centers (ASCs), however, are growing rapidly as outpatient care becomes more popular among patients seeking cost-effective, minimally invasive procedures. ASCs also benefit from lower infection risks and shorter patient turnaround times, making them an attractive end-use segment for flexible endoscopes.

    Regional insights
    The North American market continues to dominate, underpinned by advanced healthcare infrastructure, widespread adoption of minimally invasive techniques, and high healthcare spending. The US in particular remains the largest contributor, driven by its large patient pool, favorable reimbursement environment, and the presence of key global players with extensive R&D investments.

    The Asia-Pacific region is expected to grow at the fastest pace, supported by rapid healthcare infrastructure development in countries such as China, India, and Japan. Rising chronic disease prevalence, increasing government initiatives to improve diagnostic access, and the booming medical tourism industry are key growth drivers. Local manufacturing capabilities and cost-efficient production further enhance the region’s competitive position.

    Market dynamics
    Market drivers

    Rising prevalence of chronic conditions such as cancer, gastrointestinal disorders, and respiratory diseases.

    Growing demand for minimally invasive procedures that reduce hospital stays and recovery times.

    Advancements in AI-assisted imaging and robotic endoscopy systems.

    Expanding healthcare infrastructure in emerging economies.

    Market restraints
    High production and procedural costs limiting accessibility in developing countries.

    Stringent regulatory requirements delaying product approvals.

    Complex sterilization procedures impacting operational efficiency.

    Market opportunities
    Rising adoption of single-use flexible endoscopes to prevent cross-contamination.

    Integration of AI-enabled diagnostics for enhanced accuracy and efficiency.

    Expansion into emerging markets with growing healthcare budgets.

    Development of cost-effective, portable endoscopes for outpatient and remote care settings. Infinium Global Research

  • FDA to pause New Device Applications during shutdown

    FDA to pause New Device Applications during shutdown

    The FDA said it will not accept new medical device submissions that require payment of user fees during the Trump administration’s latest government shutdown.

    U.S. federal government agencies shut down on Wednesday, as lawmakers in Congress failed to reach a bipartisan deal to extend government funding ahead of the Oct. 1 deadline.

    According to the agency’s contingency plan, reviews of existing submissions and requests to conduct important clinical research can continue using carryover user fee funding. FDA also said it will maintain work related to imminent threats to human life, including recalls, adverse event surveillance, import reviews, for-cause inspections and enforcement actions.

    Medical device user fees support the review and approval of new medical products, reviews of important clinical research requests, the issuance of guidance and other necessary activities that still allow patients to access new therapies, according to the FDA.

    However, most device programs without carryover funding are paused. That includes pre-approval inspections and policy development not directly tied to urgent safety issues. Regulatory science research and longer-term innovation efforts are also curtailed until appropriations are restored.

    President Donald Trump and Vice President JD Vance have indicated in press conferences about the shutdown that layoffs will happen if the shutdown continues for weeks. Office of Management and Budget Director Russ Vought said on a call that reduction-in-force and layoffs would happen in the next two days, CBS News reported. However, FDA Commissioner Marty Makary reportedly told employees that FDA would not have any mass firings as part of the government shutdown, according to Bloomberg Law.

    In its contingency plan, FDA said 13,872 employees – about 86% of its workforce – will keep working during the shutdown. That includes 10,740 exempt staff funded by carryover user fees and 3,132 excepted staff whose roles are necessary to protect human life or government property.

    The pause is expected to affect device makers preparing to file new 510(k), de novo or PMA submissions. Manufacturers with ongoing submissions may see less disruption in the short term, as those reviews can continue under existing fee funding.

    FDA said in a LinkedIn post, “All FDA activities related to imminent threats to the safety of human life or protection of property will continue. This includes detecting and responding to public health emergencies and continuing to address existing critical public health challenges by managing recalls, mitigating drug shortages, and responding to outbreaks related to foodborne illness and infectious diseases. It also includes surveillance of adverse event reports for issues that could cause human harm, the review of import entries to determine potential risks to human health, conducting for cause and certain surveillance inspections of regulated facilities, and related regulatory testing activities, and criminal enforcement work and certain civil investigations.”

    How the FDA operates in a government shutdown
    Medical device companies pay fees to FDA when they register their businesses and list their devices with the agency, whenever they submit an application or a notification to market a new medical device in the U.S., and for certain other types of submissions. These actions fall under the Medical Device User Fee Amendments. Medical Design & Outsourcing

  • TN sets up expert panel on AI in Healthcare

    TN sets up expert panel on AI in Healthcare

    An expert committee formed to explore the role of Artificial Intelligence (AI) in the State’s healthcare sector has representation from both health authorities and academic institutions.

    The committee will meet periodically to assess the use of AI in healthcare and analyse the scope for development and deployment in healthcare institutions in Tamil Nadu. It will also explore ways to utilise the data as per Tamil Nadu Government’s Data Policy for further development of cost-effective AI technologies in higher education and research institutions.

    The Health Secretary will chair the 20-member committee. It includes senior health officials such as Managing Director, Tamil Nadu Medical Services Corporation, Project Director, Tamil Nadu Health Systems Project, Mission Director, National Health Mission – Tamil Nadu, Commissioner of Food Safety and Drug Administration, directors of Medical Education and Research, Medical and Rural Health Services and Public Health and Preventive Medicine, State TB Officer and Project Director, Tamil Nadu State Blindness Control Society.

    Other members include a professor of Radiology, Barnard Institute of Radiology, Madras Medical College (MMC), a professor of Respiratory Medicine, MMC, an associate professor of Community Medicine, K.A.P. Viswanatham Government Medical College, Tiruchi and an associate professor (Dermatology, Venereal and Leprosy) of Stanley Medical College. Representatives of REACH, a NGO working in the field of TB, Christian Medical College, Vellore, Indian Institute of Technology, Madras, Anna University and Vellore Institute of Technology, Vellore are part of the committee.

    In a recent order, the Health department noted that AI has emerged as a major new field in healthcare, and is helping the medical profession in the early diagnosis of diseases such as cancer.

    An expert committee formed to explore the role of Artificial Intelligence (AI) in the State’s healthcare sector has representation from both health authorities and academic institutions.

    The committee will meet periodically to assess the use of AI in healthcare and analyse the scope for development and deployment in healthcare institutions in Tamil Nadu. It will also explore ways to utilise the data as per Tamil Nadu Government’s Data Policy for further development of cost-effective AI technologies in higher education and research institutions.

    The Health Secretary will chair the 20-member committee. It includes senior health officials such as Managing Director, Tamil Nadu Medical Services Corporation, Project Director, Tamil Nadu Health Systems Project, Mission Director, National Health Mission – Tamil Nadu, Commissioner of Food Safety and Drug Administration, directors of Medical Education and Research, Medical and Rural Health Services and Public Health and Preventive Medicine, State TB Officer and Project Director, Tamil Nadu State Blindness Control Society.

    Other members include a professor of Radiology, Barnard Institute of Radiology, Madras Medical College (MMC), a professor of Respiratory Medicine, MMC, an associate professor of Community Medicine, K.A.P. Viswanatham Government Medical College, Tiruchi and an associate professor (Dermatology, Venereal and Leprosy) of Stanley Medical College. Representatives of REACH, a NGO working in the field of TB, Christian Medical College, Vellore, Indian Institute of Technology, Madras, Anna University and Vellore Institute of Technology, Vellore are part of the committee.

    In a recent order, the Health department noted that AI has emerged as a major new field in healthcare, and is helping the medical profession in the early diagnosis of diseases such as cancer.

    An expert committee formed to explore the role of Artificial Intelligence (AI) in the State’s healthcare sector has representation from both health authorities and academic institutions.

    The committee will meet periodically to assess the use of AI in healthcare and analyse the scope for development and deployment in healthcare institutions in Tamil Nadu. It will also explore ways to utilise the data as per Tamil Nadu Government’s Data Policy for further development of cost-effective AI technologies in higher education and research institutions.

    The Health Secretary will chair the 20-member committee. It includes senior health officials such as Managing Director, Tamil Nadu Medical Services Corporation, Project Director, Tamil Nadu Health Systems Project, Mission Director, National Health Mission – Tamil Nadu, Commissioner of Food Safety and Drug Administration, directors of Medical Education and Research, Medical and Rural Health Services and Public Health and Preventive Medicine, State TB Officer and Project Director, Tamil Nadu State Blindness Control Society.

    Other members include a professor of Radiology, Barnard Institute of Radiology, Madras Medical College (MMC), a professor of Respiratory Medicine, MMC, an associate professor of Community Medicine, K.A.P. Viswanatham Government Medical College, Tiruchi and an associate professor (Dermatology, Venereal and Leprosy) of Stanley Medical College. Representatives of REACH, a NGO working in the field of TB, Christian Medical College, Vellore, Indian Institute of Technology, Madras, Anna University and Vellore Institute of Technology, Vellore are part of the committee.

    In a recent order, the Health department noted that AI has emerged as a major new field in healthcare, and is helping the medical profession in the early diagnosis of diseases such as cancer.

    ‘E-paarvai’
    The State has already implemented AI-based initiatives such as ‘e-paarvai’ and digital x-ray analysis for tuberculosis diagnosis.

    ‘E-paarvai’ is a mobile appliation that leverages AI to detect cataracts during eye screenings. In TB, AI plays a crucial role in active case finding. The AI system rapidly interprets these images and flags those that are highly suggestive of TB, officials said.

    Highlighting AI as a “game changer” in many healthcare innovations, the department said that the formation of an expert committee to analyse emerging technology in healthcare in a way suitable for Tamil Nadu is vital.

    The expert committee has been tasked with analysing and discussing emerging AI algorithms, and development using higher education institutions and deployment in the State’s healthcare sector. The Hindu

  • India considers One-Time settlement of Vi’s dues

    India considers One-Time settlement of Vi’s dues

    India is considering a one-time settlement of its longstanding demand for billions of dollars in past-due fees from Vodafone Group Plc’s beleaguered local venture, as the government seeks to strengthen ties with the UK, people familiar with the matter said.

    Resolution in the nearly 2 trillion rupees ($22.5 billion) financial dispute may come through a waiver of interest and penalties, followed by a concession on the principal for Vodafone Idea Ltd., said the people, who asked not to be identified as the discussions are private.

    A deal would throw a lifeline to India’s third-largest wireless operator, shore up competition in a sector dominated by Reliance Jio Infocomm Ltd. as well as signal to global investors that New Delhi wants to remedy its reputation for unpredictable policy measures.

    It’s also a calculated diplomatic gesture toward the UK soon after the two countries inked a trade pact and just as Prime Minister Keir Starmer prepares to visit India this week. With US ties fraying under President Donald Trump and relations with China just beginning to warm, India may use any settlement with Vodafone Idea to anchor the UK as a more dependable economic partner and show that it can be pragmatic when strategic interests demand.

    Indian officials are drafting the framework and also weighing steps to ensure any deal doesn’t spark legal challenges from other telecom operators that owe dues, the people said.

    Attract investors
    The arrears have hung over the joint venture formed by the merger of the British firm’s local unit with billionaire Kumar Mangalam Birla’s Idea Cellular Ltd. It hasn’t reported a quarterly profit since 2016. A settlement would potentially pave the way for the wireless carrier to attract new investors, the people added.

    Starmer’s scheduled visit has added urgency to the effort, one of the people said.

    A representative for Vodafone Idea and India’s telecom ministry did not respond to an email seeking comments on the resolution proposal.

    The Indian government, which became Vodafone Idea’s 49% shareholder this year through a debt-to-equity swap, has publicly acknowledged the need for a solution. A government counsel told the Supreme Court last month that “some solution may be required” given public funds are now tied up in the carrier.

    The dispute itself pertains to how India calculates annual adjusted gross revenue (AGR), a share of which is paid as license and spectrum fees. While telecom carriers have challenged the method for years, the court may be more receptive this time if the government shifts its stance, one of the people said.

    No unfair advantage
    To be sure, officials will have to ensure that all telecom operators are treated fairly in the process of granting AGR relief — Sunil Mittal’s Bharti Airtel Ltd. and the Tata Group’s wireless carrier have also been seeking relief. One option under discussion is to seek revival plans from all operators in exchange for any concession, ensuring that Vodafone Idea isn’t given an unfair advantage over peers.

    Vodafone Idea has been in urgent need of capital infusion and any potential deal with a new partner hinges on clarity around the AGR burden, the people said.

    If New Delhi proceeds with a solution, it would mark the most significant intervention yet in India’s telecom sector since the government stepped in to take a near-majority stake in Vodafone Idea.

    The country’s top court on Monday deferred a hearing on the company petition challenging the AGR dues calculation to Oct. 13. Bloomberg

  • TikTok registration blocked in Indonesia over data rules

    TikTok registration blocked in Indonesia over data rules

    Indonesia said it has suspended TikTok’s registration status as an electronic system provider after it failed to hand over all data relating to the use of its live stream feature, though the social media app was still accessible to users on Friday.

    Alexander Sabar, an official at Indonesia’s communications and digital ministry, said in a statement some accounts with ties to online gambling activities used TikTok’s live stream feature during recent national protests and monetised it.

    Protests rocked the world’s third-largest democracy over exorbitant lawmaker allowances and police brutality from late August to September. TikTok temporarily suspended its live feature during the protests, saying this was intended to “keep TikTok a safe and civil space.”

    Sabar said the government subsequently asked the company for its traffic, streaming and monetisation data. The company, owned by China’s ByteDance, only provided partial data, citing its internal procedures, Sabar said.

    “So the communications and digital ministry deemed TikTok to have violated its obligations as a private electronic provider,” and suspended its registration, he said.

    The regulation regarding the list states every company that has signed up to Indonesia’s licensing rules must hand over its data to the government for the purpose of supervision or risk being blocked.

    It was unclear if access to TikTok in Indonesia was fully blocked. Reuters was able to access the application as normal. Reuters